Ticker
PACBCompany Name
PACIFIC BIOSCIENCES OF CALIFORNIA INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -152.31M | -97.57% | $ 156.11M |
3/31/2025 | $ -178.13M | -116.92% | $ 152.36M |
12/31/2024 | $ -212.25M | -137.81% | $ 154.01M |
9/30/2024 | $ -239.56M | -138.36% | $ 173.15M |
6/30/2024 | $ -260.9M | -138.14% | $ 188.87M |
3/31/2024 | $ -249.16M | -124.31% | $ 200.43M |
12/31/2023 | $ -268.02M | -133.66% | $ 200.52M |
9/30/2023 | $ -273.9M | -161.58% | $ 169.52M |
6/30/2023 | $ -275.13M | -188.27% | $ 146.14M |
3/31/2023 | $ -295.71M | -220.63% | $ 134.03M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for PACIFIC BIOSCIENCES OF CALIFORNIA INC is calculated as follows: FCF [ $ 14.47M ] / Revenues [ $ 79.69M ]
(=) FCF % [ 18.16% ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |